Download PDF
Semin Plast Surg 2007; 21(4): 226-233
DOI: 10.1055/s-2007-991192
© Thieme Medical Publishers

Immune Responses in Transplantation: Application to Composite Tissue Allograft

Aleksandra Klimczak1 , Maria Siemionow1
  • 1Department of Plastic Surgery, The Cleveland Clinic, Cleveland, Ohio
Further Information

Publication History

Publication Date:
27 November 2007 (online)

    Permissions and Reprints

ABSTRACT

After announcements of successful hand, larynx, knee, muscle, nerve, and, most recently, face transplantation, composite tissue allografts (CTAs) have been introduced into the armamentarium of plastic and reconstructive surgery. Because the microsurgical techniques required to perform CTA transplants are well established and used in daily practice by plastic surgeons, the immunologic aspects of transplantation remain of great interest to plastic surgeons. CTAs offer a unique potential for coverage of large multitissue defects; however, compared with the relatively homogenous tissue of solid organ transplants, the heterogenicity of tissue components of CTA may generate high immunologic responses. Although modern immunosuppressive agents significantly improve successful allograft acceptance, chronic allograft rejection as well as immunosuppressive drug toxicity remain major problems in the clinical practice of transplantation. The major goal of transplantation immunology is to develop tolerance to allograft transplants and long-term drug-free survival. Several experimental protocols have been designed to develop tolerance; however, none of them have been proved to induce tolerance in clinical transplantation. This review outlines the mechanisms of allograft acceptance and rejection and describes the barriers to transplantation tolerance based on our current knowledge as it applies to solid organs and CTA transplants. The review also describes innovative immunosuppressive protocols.

KEYWORDS

Composite tissue allograft - immune response - immunosuppression

REFERENCES

  • 1 Dubernard J M, Owen E, Herzberg G et al.. Human hand allograft: report on first 6 months.  Lancet. 1999;  353 1315-1320
    CrossrefPubMedGoogle Scholar
  • 2 Lanzetta M, Petruzzo P, Dubernard J M et al.. Second Report (1998-2006) of the International Registry of Hand and Composite Tissue Transplantation.  Transplant Immunology. 2007;  18 1-6
    CrossrefPubMedGoogle Scholar
  • 3 Strome M, Stein J, Esclamado R. Laryngeal transplantation and 40-month follow-up.  N Engl J Med. 2001;  344 1676-1679
    CrossrefPubMedGoogle Scholar
  • 4 Guimberteau J C, Baudet J, Panconi B, Boileau R, Potaux L. Human allotransplant of a digital flexion system vascularized on the ulnar pedicle: a preliminary report and 1-year follow-up of two cases.  Plast Reconstr Surg. 1992;  89 1135-1147
    PubMedGoogle Scholar
  • 5 Mackinnon S E, Doolabh V B, Novak C B, Trulock E P. Clinical outcome following nerve allograft transplantation.  Plast Reconstr Surg. 2001;  107 1419-1429
    CrossrefPubMedGoogle Scholar
  • 6 Levi D M, Tzakis A, Kato T et al.. Transplantation of the abdominal wall.  Lancet. 2003;  361 2173-2176
    CrossrefPubMedGoogle Scholar
  • 7 Devauchelle B, Badet L, Lengele B et al.. First human face allograft: early report.  Lancet. 2006;  368 203-209
    CrossrefPubMedGoogle Scholar
  • 8 Lee W P, Yaremchuk M J, Pan Y C, Randolph M A, Tan C M, Weiland A J. Relative antigenicity of components of a vascularized limb allograft.  Plast Reconstr Surg. 1991;  87 401-411
    CrossrefPubMedGoogle Scholar
  • 9 Ulusal B G, Ulusal A E, Ozmen S, Zins J E, Siemionow M. A new composite facial and scalp transplantation model in the rat.  Plast Reconstr Surg. 2003;  112 1302-1311
    CrossrefPubMedGoogle Scholar
  • 10 Demir Y, Ozmen S, Klimczak A, Mukherjee A, Siemionow M. Tolerance induction in composite facial tissue allograft transplantation in the rat model.  Plast Reconstr Surg. 2004;  114 1790-1801
    CrossrefPubMedGoogle Scholar
  • 11 Siemionow M Z, Demir Y, Mukerjee A, Klimczak A. Development and maintenance of donor specific chimerism in semi-allogenic and fully MHC mismatched facial allograft transplants.  Transplantation. 2005;  79 558-567
    CrossrefPubMedGoogle Scholar
  • 12 Siemionow M, Izycki D, Zielinski M. Donor-specific tolerance in fully major histocompatibility complex-mismatched limb allograft transplants under an anti-alpha beta T-cell receptor monoclonal antibody and cyclosporine A protocol.  Transplantation. 2003;  76 1662-1668
    CrossrefPubMedGoogle Scholar
  • 13 Siemionow M, Izycki D, Ozer K, Ozmen S, Klimczak A. Role of thymus in operational tolerance induction in limb allograft transplant model.  Transplantation. 2006;  81 1568-1576
    CrossrefPubMedGoogle Scholar
  • 14 Hettiaratchy S, Randolph M A, Petit F, Lee W P, Butler P E. Composite tissue allotransplantation-a new era in plastic surgery?.  Br J Plast Surg. 2004;  57 381-391
    CrossrefPubMedGoogle Scholar
  • 15 Aw M M. Transplant immunology.  J Pediatr Surg. 2003;  38 1275-1280
    CrossrefPubMedGoogle Scholar
  • 16 Roitt I, Brostoff J, Male D. Immunolgy. 5th ed. London; Mosby International Ltd 1998
    Google Scholar
  • 17 Krieger N R, Yin D P, Fathman C G. CD4 + but not CD8 + cells are essential for allorejection.  J Exp Med. 1996;  184 2013-2018
    CrossrefPubMedGoogle Scholar
  • 18 Sayegh M H, Turka L A. The role of T-cell costimulatory activation pathways in transplant rejection.  N Engl J Med. 1998;  338 1813-1821
    CrossrefPubMedGoogle Scholar
  • 19 Zhai Y, Ghobrial R M, Busuttil R W, Kupiec-Weglinski J W. Th1 and Th2 cytokines in organ transplantation: paradigm lost?.  Crit Rev Immunol. 1999;  19 155-172
    PubMedGoogle Scholar
  • 20 Womer K L, Sayegh M H, Auchincloss Jr H. Involvement of the direct and indirect pathways of allorecognition in tolerance induction.  Philos Trans R Soc Lond B Biol Sci. 2001;  356 639-647
    PubMedGoogle Scholar
  • 21 Cendales L C, Kirk A D, Moresi J M, Ruiz P, Kleiner D E. Composite tissue allotransplantation: classification of clinical acute skin rejection.  Transplantation. 2005;  80 1676-1680
    PubMedGoogle Scholar
  • 22 Rocha P N, Plumb T J, Crowley S D, Coffman T M. Effector mechanisms in transplant rejection.  Immunol Rev. 2003;  196 51-64
    CrossrefPubMedGoogle Scholar
  • 23 Hancock W W, Gao W, Shemmeri N et al.. Immunopathogenesis of accelerated allograft rejection in sensitized recipients: humoral and nonhumoral mechanisms.  Transplantation. 2002;  73 1392-1397
    CrossrefPubMedGoogle Scholar
  • 24 Williams J M, Holzknecht Z E, Plummer T B et al.. Acute vascular rejection and accommodation: divergent outcomes of the humoral response to organ transplantation.  Transplantation. 2004;  78 1471-1478
    CrossrefPubMedGoogle Scholar
  • 25 Kanitakis J, Jullien D, Petruzzo P et al.. Clinicopathologic features of graft rejection of the first human hand allograft.  Transplantation. 2003;  76 688-693
    CrossrefPubMedGoogle Scholar
  • 26 Kanitakis J, Badet L, Petruzzo P et al.. First human face allotransplantation: monitoring of rejection with a pathlogical score assessing human composite tissue allograft rejection [abstract 967].  Transplantation. 2006;  82(Suppl 3) 392
    PubMedGoogle Scholar
  • 27 Moll S, Pascual M. Humoral rejection of organ allografts.  Am J Transplant. 2005;  5 2611-2618
    CrossrefPubMedGoogle Scholar
  • 28 Petruzzo P, Badet L, Gazarian A et al.. Bilateral hand transplantation: six years after the first case.  Am J Transplant. 2006;  6 1718-1724
    CrossrefPubMedGoogle Scholar
  • 29 Cendales L C, Xu H, Bacher J et al.. Composite tissue allotransplantation: development of a preclinical model in nonhuman primates.  Transplantation. 2005;  80 1447-1454
    CrossrefPubMedGoogle Scholar
  • 30 Joosten S A, Sijpkens Y W, van Kooten C, Paul L C. Chronic renal allograft rejection: pathophysiologic considerations.  Kidney Int. 2005;  68 1-13
    CrossrefPubMedGoogle Scholar
  • 31 Womer K L, Stone J R, Murphy B, Chandraker A, Sayegh M H. Indirect allorecognition of donor class I and II major histocompatibility complex peptides promotes the development of transplant vasculopathy.  J Am Soc Nephrol. 2001;  12 2500-2506
    PubMedGoogle Scholar
  • 32 Takada M, Nadeau K C, Hancock W W et al.. Effects of explosive brain death on cytokine activation of peripheral organs in the rat.  Transplantation. 1998;  65 1533-1542
    CrossrefPubMedGoogle Scholar
  • 33 Kuecuek O, Mantouvalou L, Klemz R et al.. Significant reduction of proinflammatory cytokines by treatment of the brain-dead donor.  Transplant Proc. 2005;  37 387-388
    CrossrefPubMedGoogle Scholar
  • 34 Takada M, Nadeau K C, Shaw G D, Marquette K A, Tilney N L. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand.  J Clin Invest. 1997;  99 2682-2690
    PubMedGoogle Scholar
  • 35 Gorantla V S, Barker J H, Jones Jr J W et al.. Immunosuppressive agents in transplantation: mechanism of action and current anti-rejection strategies.  Microsurgery. 2000;  20 420-429
    CrossrefPubMedGoogle Scholar
  • 36 Fehr T, Sykes M. Tolerance induction in clinical transplantation.  Transpl Immunol. 2004;  13 117-130
    PubMedGoogle Scholar
  • 37 Petruzzo P, Revillard J P, Kanitakis J et al.. First human double hand transplantation: efficacy of a conventional immunosuppressive protocol.  Clin Transplant. 2003;  17 455-460
    CrossrefPubMedGoogle Scholar
  • 38 Buell J F, Gross T G, Woodle E S. Malignancy after transplantation.  Transplantation. 2005;  80(2 Suppl) S254-S264
    CrossrefPubMedGoogle Scholar
  • 39 Cherikh W S, Kauffman H M, McBride M A et al.. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival and patient survival after primary kidney transplantation.  Transplantation. 2003;  76 1289-1293
    CrossrefPubMedGoogle Scholar

Maria SiemionowM.D. Ph.D. D.Sc. 

Department of Plastic Surgery, The Cleveland Clinic

9500 Euclid Avenue, Cleveland, OH 44195

      >